Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pearson

Showing results (931-940 of 1,112) with videos related to

Pageof 112
Sort By:
Journal of Neurology|November 10, 2022
Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee studyHarry L Hébert, Abirami Veluchamy, Georgios Baskozos, et al.
Communications Medicine|February 22, 2023
Higher mitochondrial DNA copy number is associated with metformin-induced weight lossJing Wang, Hua Liang, Rong Huang, et al.
The Journal of Chemical Physics|March 2, 2022
A β-NMR study of the depth, temperature, and molecular-weight dependence of secondary dynamics in polystyrene: Entropy-enthalpy compensation and dynamic gradients near the free surfaceIain McKenzie, Derek Fujimoto, Victoria L Karner, et al.
Clinical Pharmacology and Therapeutics|October 2, 2009
Loss-of-function CYP2C9 variants improve therapeutic response to sulfonylureas in type 2 diabetes: a Go-DARTS studyK Zhou, L Donnelly, L Burch, et al.
American Heart Journal|August 9, 2005
Improved long-term survival associated with stent deployment during percutaneous coronary interventions: results from a registry of 3399 patientsJoseph B Muhlestein, Jeffrey L Anderson, ChangZong Cui, et al.
Diabetes|April 2, 2009
Reduced-function SLC22A1 polymorphisms encoding organic cation transporter 1 and glycemic response to metformin: a GoDARTS studyKaixin Zhou, Louise A Donnelly, Charlotte H Kimber, et al.
The Journal of Biological Chemistry|May 31, 2022
The Toxoplasma glucan phosphatase TgLaforin utilizes a distinct functional mechanism that can be exploited by therapeutic inhibitorsRobert D Murphy, Tiantian Chen, Jianping Lin, et al.
Diabetes, Obesity & Metabolism|November 19, 2016
Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetesDavid Preiss, Adem Dawed, Paul Welsh, et al.
The Laryngoscope|December 1, 1980
Anti-EBV serologic tests for nasopharyngeal carcinomaH B Neel, G R Pearson, L H Weiland, et al.
Diabetologia|June 5, 2024
Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approachLaura M Güdemann, Katie G Young, Nicholas J M Thomas, et al.
Pageof 112

Showing results (931-940 of 1,112) with videos related to

Sort By:
Pageof 112
Journal of Neurology|November 10, 2022
Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee studyHarry L Hébert, Abirami Veluchamy, Georgios Baskozos, et al.
Communications Medicine|February 22, 2023
Higher mitochondrial DNA copy number is associated with metformin-induced weight lossJing Wang, Hua Liang, Rong Huang, et al.
The Journal of Chemical Physics|March 2, 2022
A β-NMR study of the depth, temperature, and molecular-weight dependence of secondary dynamics in polystyrene: Entropy-enthalpy compensation and dynamic gradients near the free surfaceIain McKenzie, Derek Fujimoto, Victoria L Karner, et al.
Clinical Pharmacology and Therapeutics|October 2, 2009
Loss-of-function CYP2C9 variants improve therapeutic response to sulfonylureas in type 2 diabetes: a Go-DARTS studyK Zhou, L Donnelly, L Burch, et al.
American Heart Journal|August 9, 2005
Improved long-term survival associated with stent deployment during percutaneous coronary interventions: results from a registry of 3399 patientsJoseph B Muhlestein, Jeffrey L Anderson, ChangZong Cui, et al.
Diabetes|April 2, 2009
Reduced-function SLC22A1 polymorphisms encoding organic cation transporter 1 and glycemic response to metformin: a GoDARTS studyKaixin Zhou, Louise A Donnelly, Charlotte H Kimber, et al.
The Journal of Biological Chemistry|May 31, 2022
The Toxoplasma glucan phosphatase TgLaforin utilizes a distinct functional mechanism that can be exploited by therapeutic inhibitorsRobert D Murphy, Tiantian Chen, Jianping Lin, et al.
Diabetes, Obesity & Metabolism|November 19, 2016
Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetesDavid Preiss, Adem Dawed, Paul Welsh, et al.
The Laryngoscope|December 1, 1980
Anti-EBV serologic tests for nasopharyngeal carcinomaH B Neel, G R Pearson, L H Weiland, et al.
Diabetologia|June 5, 2024
Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approachLaura M Güdemann, Katie G Young, Nicholas J M Thomas, et al.
Pageof 112